SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hongwei Chen, Jinlin Miao, Hongchen Li, Chunhua Wang, Junliang Li, Yong Zhu, Jianxin Wang, Xia Wu, Hongying Qiao, Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma, Journal of Surgical Research, 2014, 189, 1, 81

    CrossRef

  2. 2
    Jie Yin, Ji-Min Zhu, Xi-Zhong Shen, The role and therapeutic implications of RING-finger E3 ubiquitin ligases in hepatocellular carcinoma, International Journal of Cancer, 2014, 135, 1
  3. 3
    Yatendra Kumar Satija, Abhishek Bhardwaj, Sanjeev Das, A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer, International Journal of Cancer, 2013, 133, 12
  4. 4
    X.R. Wu, J.J. Sha, D.M. Liu, Y.H. Chen, G.L. Yang, J. Zhang, Y.Y. Chen, J.J. Bo, Y.R. Huang, High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma, European Journal of Surgical Oncology (EJSO), 2013, 39, 1, 100

    CrossRef

  5. 5
    Hao Yang, Feng Fang, Ruimin Chang, Lianyue Yang, MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma, Hepatology, 2013, 58, 1
  6. 6
    Ilaria Marzi, Maria Grazia Cipolleschi, Massimo D'Amico, Theodora Stivarou, Elisabetta Rovida, Maria Cristina Vinci, Silvia Pandolfi, Persio Dello Sbarba, Barbara Stecca, Massimo Olivotto, The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming, Cell Cycle, 2013, 12, 2, 353

    CrossRef

  7. 7
    Feng Fang, Lianyue Yang, Yiming Tao, Wei Qin, FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo, Cancer, 2012, 118, 1
  8. 8
    Yong-Sam Jung, Yingjuan Qian, Xinbin Chen, Pirh2 RING-finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy, FEBS Letters, 2012, 586, 10, 1397

    CrossRef

  9. 9
    L. Hu, M. Liu, L. Chen, T. H. M. Chan, J. Wang, K.-k. Huo, B.-J. Zheng, D. Xie, X.-Y. Guan, SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma, Carcinogenesis, 2012, 33, 8, 1581

    CrossRef

  10. You have open access to this content10
    Zhihao Wang, Bo Yang, Lanlan Dong, Biwen Peng, Xiaohua He, Wanhong Liu, A novel oncoprotein Pirh2: rising from the shadow of MDM2, Cancer Science, 2011, 102, 5
  11. 11
    Xiaodong Huang, Xiaoli Qian, Chun Cheng, Song He, Linlin Sun, Qing Ke, Li Zhang, Xia Pan, Fei He, Qiuhong Wang, Jie Meng, Runzhou Ni, Aiguo Shen, Expression of Pirh2, a p27Kip1 ubiquitin ligase, in hepatocellular carcinoma: correlation with p27Kip1 and cell proliferation, Human Pathology, 2011, 42, 4, 507

    CrossRef

  12. 12
    Gang Wu, Meiqian Sun, Liping Zhang, Juan Zhou, Yi Wang, Keke Huo, A novel hPirh2 splicing variant without ubiquitin protein ligase activity interacts with p53 and is down-regulated in hepatocellular carcinoma, FEBS Letters, 2010, 584, 13, 2772

    CrossRef